MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway - Wikidata - thesis-toulmin - TriplyDB

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

http://www.wikidata.org/entity/Q28268117

about

Regulation of TAZ in cancer The Roles of NDR Protein Kinases in Hippo Signalling Mechanisms of Hippo pathway regulation MAP4K4: an emerging therapeutic target in cancer DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2 Fluid shear stress activates YAP1 to promote cancer cell motility DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways.MST1/MST2 Protein Kinases: Regulation and Physiologic Roles.YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity Substrate Affinity Differentially Influences Protein Kinase C Regulation and Inhibitor Potency.The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.Overlapping functions of the MAP4K family kinases Hppy and Msn in Hippo signaling.The Hippo signal transduction network for exercise physiologists Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.Regulation of Hippo signalling by p38 signalling.Disease implication of hyper-Hippo signalling.Dendritic cell MST1 inhibits Th17 differentiation.Altered signaling associated with chronic arsenic exposure in human skin keratinocytes.Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP.Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD).The Hippo pathway in intestinal regeneration and disease.Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network.YAP/TAZ at the Roots of Cancer.Crosstalk between Hippo signalling and miRNAs in tumour progression.Targeting the Hippo signalling pathway for cancer treatment.Expression and significance of Hippo/YAP signaling in glioma progression.The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.Kidney-specific knockout of Sav1 in the mouse promotes hyperproliferation of renal tubular epithelium through suppression of the Hippo pathway.Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration.MicroRNA Regulates Hepatocytic Differentiation of Progenitor Cells by Targeting YAP1.NF2 Activates Hippo Signaling and Promotes Ischemia/Reperfusion Injury in the Heart.Mapping the STK4/Hippo signaling network in prostate cancer cell.Characterization of Hippo Pathway Components by Gene Inactivation.An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice.Regulation of the Hippo Pathway Transcription Factor TEAD.Angiomotin-like 2 interacts with and negatively regulates AKT.

P2860

Q26740462-09144B74-8E3B-4D59-A800-3EBE91E8B50B Q26746889-631E39EB-4C02-4E97-A882-ACE12F35BA4A Q26771285-4DA8D2C2-352A-45E4-9B12-FC81925B9967 Q28068524-1CBD8123-B200-4B4C-82DD-CFEBBE57ADC3 Q29871129-AF33D009-C89B-446D-9097-7DA2ABF4D631 Q30835797-E05CDB40-32D0-4890-8CE8-A7B3A1E4527F Q33607399-B876C98B-8935-4B2D-AB35-FE8CCAC32438 Q33821181-5AA7C120-FD8C-4576-B9C2-4627F943AF52 Q33913845-171C7298-A32D-4569-9B24-5A6404C25B85 Q34546530-786951F7-19D2-46B7-9E36-04F3B048BEEC Q36111069-578C9BB7-25C0-4960-97C3-1003B8B58973 Q36209802-AB857A73-B69C-4F4D-AFC0-408C79C3537E Q36350091-D47E0BFC-B81F-4CDA-8365-6E578512E73E Q36882496-52A03AA0-AEC4-4D48-82F7-1AB9064A4CBA Q36902243-E3FB4392-DAB8-46B9-BB11-09EF7C0557F3 Q37018393-9A5D7B42-F104-4198-B3B4-EDD069BD3DEA Q37026412-76BD576B-3B76-481A-8887-51FF9AEDCC76 Q37190772-7748D83B-5F3D-42A1-A7D2-26939A05683F Q37385782-0973447F-9DEE-4C78-A283-E79F9E1EF6C5 Q37630340-3B7B08B4-0C4B-4D44-A4CB-C5DB9D8270AF Q38373554-6F2992B0-DDC3-4535-92A6-5C4948452A7B Q38407576-E61AD371-13B4-4540-9764-E7EC000F10D9 Q38655714-EEAB8DDB-CAFD-4F00-B878-ED132F4170C1 Q38760403-B363D092-3F0F-4D89-B80D-582456940090 Q38826172-048BA30E-3F4E-4985-8E73-E7295BCB31F6 Q38857144-02F50650-235E-43EA-90A3-F6D9A90358D4 Q38864941-94C8BBB4-A092-4F80-8C94-2FC2E3C3115A Q39038455-D3D2E14D-22DB-4FED-9B9B-1B5B188D67FC Q39047762-355D5289-288E-476B-9E50-DC7DCD227DE1 Q39310380-C122AFCD-5757-4D60-BAE8-DE88F2849389 Q39394211-F8A74F59-54A5-4D20-8042-31A343D47902 Q40778207-E4A2FCC2-F2F6-4961-86B9-247BE2E25136 Q41002708-2483905A-86EC-41D4-9544-8575DE40F1A7 Q41144036-50022220-39E3-4E60-BA9B-99AA5A82D1DC Q41492288-50ACA920-8185-4407-8810-1D4218F8B075 Q41569513-DAC71586-722A-424B-8B0B-B7218B7F98BE Q45423657-A37945F6-0A15-4A74-A793-B6F427EEA440 Q46062152-BA18FD63-5ACC-4DE4-BF19-DF17DE8B0002 Q46092496-26529A80-C42C-4320-89FA-B16272C8490C Q46151218-F0062005-FEDA-4016-8740-5BEA1AA84AB0

P2860

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

http://www.wikidata.org/entity/Q28268117

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@ast

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@en

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@nl

type

label

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@ast

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@en

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@nl

prefLabel

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@ast

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@en

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@nl

P1433

Q28268117-7E2926B7-A50C-43C0-8F36-972773BDCC21

P1476

Q28268117-C1DD41FC-9922-4598-9D07-4F89512D2710

P2093

Q28268117-19548151-92EF-45ED-9D41-B90C03226A24

Q28268117-3A6FC42D-3E86-4591-BAC0-EBD8E19A4BB2

Q28268117-3E9C8670-6070-47E8-99E0-C3CAEE585179

Q28268117-402FF8E3-CE25-4613-A4FF-D25230ABF5E7

Q28268117-41FE5617-970F-475F-A92C-8E1E491F57DA

Q28268117-42B9663E-1533-4F11-9359-9C88055D94CB

Q28268117-55713D24-0F0B-47BB-A50E-7041893F6CE9

Q28268117-62355CB1-E459-4FEF-B611-AD7FD084275A

Q28268117-8EEE1A0E-65ED-4588-9006-9B4E55E2505F

Q28268117-9087E41B-689B-46D3-8E78-16C2E8BA5807

P2860

Q28268117-01FBE533-9BAD-4B1B-9AC9-F647D4A347A8

Q28268117-03BB0338-1A59-401D-96B8-E4923D9295DE

Q28268117-0EBAF092-519C-4F01-ADC3-384EAA2161E8

Q28268117-15AF4E6F-06B2-462E-9314-E60D7C3591DC

Q28268117-163D5B4B-24AB-4156-92EE-EEDB2ECA94DC

Q28268117-1EE2A6EE-A4F6-4140-9278-BA7B0EA02F4D

Q28268117-205261A4-B2EF-4EE3-A9A6-5B43403EF103

Q28268117-287EEA92-6C67-4BD3-BB19-51FFC97118F0

Q28268117-354A07CE-737C-4F82-9E30-DD7ED1B3A1BA

Q28268117-374879CD-A6F2-42C1-B2B7-D2527B0D1FD4

P2888

Q28268117-2A5FA9E8-9A6F-4176-9166-4252B21C78FC

P304

Q28268117-1FC017C2-34CC-49EA-A0C6-A44528779546

P31

Q28268117-4768801D-1B15-41DE-B9CA-4B40F939AF63

P3181

Q28268117-5DEE9E75-76E9-42BF-8FFA-FA78B544CC51

P356

Q28268117-A0FCEF38-D6B5-4014-A063-8EA62D1590A7

P407

Q28268117-09E71157-4F20-4D9C-B0D0-5E5FA0A81DA6

P478

Q28268117-1142FB0F-8AE2-4D74-923C-91509553E3E4

P50

Q28268117-2670A1F0-B97B-4246-800A-56DFE9916E06

Q28268117-A0C0334C-7EA4-4B6E-B332-A7FAD3FF3DCA

Q28268117-E91DD28E-216C-4C63-A8AF-6208861EBBFA

P577

Q28268117-771FEFF3-CC40-4002-9211-DB43970E1729

P5875

Q28268117-ACAA7C2D-342B-4DD2-8FA8-1E4CDFAC0437

P6179

Q28268117-6E998459-1B7A-4178-9BCA-1DC7CE2ECEA7

P698

Q28268117-F2D5805B-7375-4FA1-BF72-D5F95FE8FC2E

P932

Q28268117-7FF95FF2-0847-4021-82F3-B7E9399F8293

P3181

P356

P1433

Nature Communications

P1476

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway

@en

P2093

Audrey W Hong

http://www.w3.org/2001/XMLSchema#string

Fa-Xing Yu

http://www.w3.org/2001/XMLSchema#string

Fabian Flores

http://www.w3.org/2001/XMLSchema#string

Hyun Woo Park

http://www.w3.org/2001/XMLSchema#string

Jung-Soon Mo

http://www.w3.org/2001/XMLSchema#string

Kun-Liang Guan

http://www.w3.org/2001/XMLSchema#string

Shicong Lu

http://www.w3.org/2001/XMLSchema#string

Steven W Plouffe

http://www.w3.org/2001/XMLSchema#string

Violaine Mottier-Pavie

http://www.w3.org/2001/XMLSchema#string

Wenqi Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Genome engineering using the CRISPR-Cas9 system

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition

Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2

The protein kinase complement of the human genome

The hippo signaling pathway in development and cancer

Multiplex genome engineering using CRISPR/Cas systems

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

P2888

P304

8357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1548075

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NCOMMS9357

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Carsten G Hansen

Toshiro Moroishi

P577

2015-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283016258

http://www.w3.org/2001/XMLSchema#string

P6179

1015913635

http://www.w3.org/2001/XMLSchema#string

P698

26437443

http://www.w3.org/2001/XMLSchema#string

P932

4600732

http://www.w3.org/2001/XMLSchema#string